18 May 2013
Keywords: mark, timney, adds, his, role, merck, co
Article | 07 January 2008
Mark Timney, managing director of MSD Korea, has also become president of US drug major Merck & Co's Japanese subsidiary, Banyu
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2008
17 May 2013
© 2013 thepharmaletter.com